Clinical trials
Observational Exfoliation Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 4 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Unknown status | 10 |
| Recruiting | 4 |
| Terminated | 3 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aristotle University Of Thessaloniki | 4 |
| Assiut University | 4 |
| St. Erik Eye Hospital | 4 |
| Davinci LTD | 2 |
| General Hospital Sveti Duh | 2 |
| Kata Culina | 2 |
| Anglia Ruskin University | 1 |
| Ankara Training and Research Hospital | 1 |
| Aurolab | 1 |
| Baskent University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Exfoliation Syndrome | 38 |
| Glaucoma, Open-Angle | 15 |
| Glaucoma | 10 |
| Cataract | 8 |
| Ocular Hypertension | 6 |
| Choroidal Effusions | 2 |
| Glaucoma, Angle-Closure | 2 |
| Hypertension | 2 |
| Aortic Aneurysm, Abdominal | 1 |
| Astigmatism | 1 |
Trials
Showing 26 to 38 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.